BioOutsource Opens New Facility in Glasgow

Double's the Company's Capacity for Biologics Contract Testing and Biosimilar Characterisation in Response to Surging Demand, and Creates 50 New Jobs

(PresseBox) ( Glasgow, Scotland, )
BioOutsource Ltd. ("BioOutsource"), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, today announced the opening of a new facility which doubles BioOutsource's capacity for future growth.

"Our opening of this new, state-of-the-art facility demonstrates our commitment to our growing list of global customers," commented BioOutsource CEO, Gerry MacKay. "Demand for our services remains high and we are doubling our capacity to make sure we are ready to support the robust pipeline of biotech and biosimilar products currently in development.

It is estimated that in opening and running the new facility, BioOutsource will create approximately 50 new jobs for scientific and technical professionals in the next six months.

Mr. MacKay continued, "This is a great opportunity for Life Science professionals to join an exciting and rapidly growing company. With the recent acquisition by Sartorius Stedim Biotech we expect to become one of the largest employers in this sector in Scotland and further investment in new services is already planned".
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.